AHW: Hot Water Drinking Therapy in Achalasia

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01863966
Collaborator
(none)
100
1
2
69
1.4

Study Details

Study Description

Brief Summary

From clinical observation that some achalasia patients drink water to help swallow food, the investigators have proposed a systemic hot water drinking therapy. This study is to observe its efficacy on achalasia symptoms and explore its mechanism.

Condition or Disease Intervention/Treatment Phase
  • Other: hot water drinking therapy
  • Procedure: Pneumatic dilation
N/A

Detailed Description

  1. Achalasia patients will participate hot water drinking therapy: to drink 200ml of hot water before and after a meal, as well as 2 hours before sleep and to chew food carefully and swallow with hot soup.

  2. Patients are followed by achalasia associated symptom scores, barium esophagram and endoscopy.

  3. If patients are unsatisfied with hot water drinking therapy, they receive pneumatic dilation

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Efficacy and Safety Study of Hot Water Drinking Therapy in Achalasia Patients
Study Start Date :
Mar 1, 2010
Anticipated Primary Completion Date :
Nov 1, 2015
Anticipated Study Completion Date :
Dec 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hot water drinking therapy

Hot water drinking before,after meal and before sleep

Other: hot water drinking therapy
Drink 200ml hot water 3min before and after a meal. Swallow food with hot water and drink 200ml hot water before sleep

Active Comparator: Pneumatic dilation

Patients who are unsatisfied with hot water drinking therapy are to receive standard pneumatic dilation

Procedure: Pneumatic dilation
Patients who are unsatisfied with hot water drinking therapy are to receive standard pneumatic dilation under endoscope

Outcome Measures

Primary Outcome Measures

  1. Change from baseline achalasia symptom score at 1 month [baseline and 1 month]

    Dysphagia, Regurgitation and Chest Pain scores

Secondary Outcome Measures

  1. Number of patients with adverse effects [Week 1]

    adverse effects of drinking water like distention, nausea and belching

  2. Change from baseline in barium esophagram at 1 year [baseline and 1 year]

    measure esophageal diameter

  3. Endoscopy at 1 year [year 1]

    esophageal bezoars and esophageal cancer

  4. Pneumatic dilation rate and relative efficacy [any time]

    Patients who are unsatisfied with hot water drinking therapy are to receive pneumatic dilation

  5. Change from baseline in achalasia symptom score at 1 year [baseline and 1 year]

    Dysphagia,Regurgitation and Chest Pain scores

  6. Change from baseline achalasia symptom scores at 5 years [baseline and 5 years]

    Dysphagia,Regurgitation and Chest Pain scores

  7. Change from baseline in barium esophagram at 5 years [baseline and 5 years]

    measure esophageal diameter

  8. Endoscopy at 5 years [year 5]

    esophageal bezoars and esophageal cancer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • achalasia patients diagnosed by endoscopy, barium esophagram and manometry
Exclusion Criteria:
  • could not drink water

  • poor compliance

  • severe comorbidities

  • esophageal stenosis secondary to erosions and cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Science Beijing China 100730

Sponsors and Collaborators

  • Peking Union Medical College Hospital

Investigators

  • Study Director: Meiyun Ke, M.D., Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Science

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT01863966
Other Study ID Numbers:
  • PUMCH-AchaWater
First Posted:
May 29, 2013
Last Update Posted:
May 29, 2013
Last Verified:
May 1, 2013
Keywords provided by Peking Union Medical College Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 29, 2013